Immunotherapy of hematologic malignancies: the road to the future.
Sotomayor
Eduardo M
EM
Loughran
Thomas P
TP
D000906:Antibodies / Q000276:immunology / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy / Q000639:trends; D005544:Forecasting; D019337:Hematologic Neoplasms / Q000276:immunology* / Q000628:therapy*; D006801:Humans; D007107:Immune System / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000276:immunology / Q000627:therapeutic use; D007167:Immunotherapy / Q000639:trends; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000276:immunology / Q000628:therapy; D016499:Radioimmunotherapy; D016896:Treatment Outcome
D000906:Antibodies; D007166:Immunosuppressive Agents